Julie D. Seroogy
- Pharmacology top 10%
- Infectious Diseases top 10%
- Epidemiology
- Molecular Medicine top 5%
- Clinical Biochemistry top 5%
- Co-authors
- Steven L. BarriereKoné KanigaJ P ShawMichael M. KittDeborah L. HigginsDavid P. NicolauJeng‐Pyng ShawKenneth L. Duchin
- Topics
- Antibiotics Pharmacokinetics and Efficacy (9 papers)Antibiotic Resistance in Bacteria (4 papers)Pneumonia and Respiratory Infections (3 papers)
- Partner nations
- United StatesGermanyGreece
In The Last Decade
Julie D. Seroogy
14 papers receiving 256 citations
Peers
Comparison fields: 5 of 45
- Pharmacology 146
- Infectious Diseases 142
- Epidemiology 86
- Molecular Medicine 80
- Clinical Biochemistry 75
Countries citing papers authored by Julie D. Seroogy
This map shows the geographic impact of Julie D. Seroogy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie D. Seroogy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie D. Seroogy more than expected).
Fields of papers citing papers by Julie D. Seroogy
This network shows the impact of papers produced by Julie D. Seroogy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie D. Seroogy. The network helps show where Julie D. Seroogy may publish in the future.
Co-authorship network of co-authors of Julie D. Seroogy
This figure shows the co-authorship network connecting the top 25 collaborators of Julie D. Seroogy. A scholar is included among the top collaborators of Julie D. Seroogy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie D. Seroogy. Julie D. Seroogy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 6 | |
| 5 | 21 | |
| 6 | 5 | |
| 7 | 11 | |
| 8 | 11 | |
| 9 | 5 | |
| 10 | 5 | |
| 11 | 1 | |
| 12 | 14 | |
| 13 | 51 | |
| 14 | 127 |
About Julie D. Seroogy
Julie D. Seroogy is a scholar working on Molecular Medicine, Pharmacology and Applied Microbiology and Biotechnology, having authored 14 papers that have together received 266 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Antibiotic Resistance in Bacteria (4 papers) and Pneumonia and Respiratory Infections (3 papers). The work is most often cited by research in Molecular Medicine (80 citations), Clinical Biochemistry (75 citations) and Applied Microbiology and Biotechnology (18 citations). Julie D. Seroogy has collaborated with scholars based in United States, Germany and Greece. Frequent co-authors include Steven L. Barriere, Koné Kaniga, J P Shaw, Michael M. Kitt, Deborah L. Higgins, David P. Nicolau, Jeng‐Pyng Shaw, Kenneth L. Duchin, Charles H. Nightingale and Jacqueline A. Gibbons. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Clinical Therapeutics and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.